The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Autism Spectrum Disorder Diagnostics Market Compare Between 2026 And 2030?
The market size for autism spectrum disorder diagnostics has exhibited substantial growth in recent years. This market is anticipated to expand from $28.87 billion in 2025 to $30.37 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. The historical increase in market size can be attributed to factors such as elevated awareness of autism spectrum disorders, the broadening of pediatric developmental screening initiatives, the accessibility of trained diagnostic professionals, the increasing application of behavioral assessment frameworks, and improved access to diagnostic services.
The autism spectrum disorder diagnostics market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $36.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast timeframe include a heightened need for early intervention services, a greater adoption of AI-supported diagnostic instruments, the broadening of tele-diagnostics platforms, increased funding in neurodevelopmental research, and enhanced consistency in diagnostic criteria. Key trends predicted for the forecast period encompass wider acceptance of digital screening methods, increased application of standardized behavioral assessment scales, the growth of diagnostic programs targeting early childhood, a greater convergence of multidisciplinary diagnostic strategies, and an elevated emphasis on prompt and precise detection.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The Autism Spectrum Disorder Diagnostics Market Growth?
The anticipated expansion of specialized diagnostic centers is set to fuel the advancement of the autism spectrum disorders diagnostic market in the future. These centers are facilities where healthcare professionals, psychologists, and various specialists are employed to carry out thorough evaluations and assessments for the diagnosis of autism spectrum disorder. The increase in specialized diagnostic centers stems from progress in diagnostics, a need for complete care, specialized professional training, ongoing research, and the recognition of autism as a significant public health concern. Such centers are crucial for boosting diagnostic precision, promoting early intervention, and bettering results for those with ASD, achieved through offering specific expertise, sophisticated diagnostic instruments, extensive assessments, customized treatment strategies, family assistance, and chances for collaborative research. For example, by July 2025, NHS England, the U.K.-based government agency delivering health services, indicated that its national Community Diagnostic Centre (CDC) Programme had sanctioned 170 CDC sites throughout England. By August 2024, 165 of these sites were active in various locations, with 135 functioning from their permanent CDC building and the remaining ones using temporary arrangements until their dedicated facilities are finalized. Consequently, the expansion of specialized diagnostic centers is a key factor propelling the expansion of the autism spectrum disorders diagnostic market.
Which Segment Types Are Examined In The Autism Spectrum Disorder Diagnostics Market Segment Study?
The autism spectrum disorder diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Behavioral And Developmental Screening Tools, Standardized Diagnostic Assessments, Genetic And Molecular Testing, Digital And AI-Based Diagnostic Tools
2) By Test Type: Observational And Questionnaire-Based Tests, Cognitive And Neurodevelopmental Assessments, Biomarker And Genetic Tests, Eye-Tracking And Sensor-Based Tests
3) By Age Group: Infants And Toddlers (0–3 years), Children (4–12 years), Adolescents And Adults
4) By End User: Hospitals And Specialty Clinics, Diagnostic And Reference Laboratories, Academic And Research Institutes
Subsegments:
1) By Behavioral And Developmental Screening Tools: Parent-Reported Screening Questionnaires, Clinician-Administered Developmental Checklists
2) By Standardized Diagnostic Assessments: Structured Behavioral Observation Assessments, Standardized Diagnostic Interviews
3) By Genetic And Molecular Testing: Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS) Panels
4) By Digital And AI-Based Diagnostic Tools: AI-Driven Behavioral Analysis Platforms, Digital Biomarker & Eye-Tracking Systems
Which Trends Are Shaping Growth In The Autism Spectrum Disorder Diagnostics Market?
Key players within the autism spectrum disorder diagnostics market are developing advanced solutions, such as devices that incorporate Dynamic Quantification of Social-Visual Engagement (DQSVE), to achieve a competitive edge. This technology captures and analyzes a child’s moment-by-moment looking behavior at a rate of 120 times per second. For instance, in September 2023, the Marcus Autism Center, a US-based nonprofit healthcare and research organization, launched the EarliPoint™ Evaluation. This is a pioneering FDA-authorized device specifically designed for the early diagnosis of autism spectrum disorder (ASD) in children aged 16 to 30 months. This innovative tool utilizes eye-tracking technology to assess children’s social interactions, significantly reducing the time required for diagnosis from several hours to approximately 12 minutes.
Which Players Are Part Of The Competitive Landscape Of The Autism Spectrum Disorder Diagnostics Market?
Major companies operating in the autism spectrum disorder diagnostics market are Quest Diagnostics, Laboratory Corporation of America LabCorp, ARUP Laboratories, Invitae, Natera, Fulgent Genetics, Myriad Genetics, Sema4, PreventionGenetics, Color Genomics, Cognoa, EarliTec Diagnostics, Eurofins Scientific, Sonic Healthcare, Cerba HealthCare, Baylor Genetics, Mayo Clinic Laboratories, Bionano Genomics, Genomind, Blueprint Genetics
Get The Full Autism Spectrum Disorder Diagnostics Market Report:
Where Is The Autism Spectrum Disorder Diagnostics Market Most Concentrated Geographically?
Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2025. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Autism Spectrum Disorder Diagnostics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Autism Spectrum Disorder Diagnostics Market 2026, By The Business Research Company
Rare Disease Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report
Autism Spectrum Disorders Treatment Market Report 2026
Clinical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model